Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): updated overall survival data after >5 years of follow-up
Titel:
Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): updated overall survival data after >5 years of follow-up
Auteur:
D'Angelo, S.P. Bhatia, S. Brohl, A.S. Hamid, O. Mehnert, J.M. Terheyden, P. Shih, K.C. Brownell, I. Lebbé, C. Lewis, K.D. Linette, G.P. Milella, M. Xiong, H. Guezel, G. Nghiem, P.T.